Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Dose-dependent response of FGF-2 for lymphangiogenesis.

Chang LK, Garcia-Cardeña G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A.

Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11658-63. Epub 2004 Aug 2.

2.

Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability.

Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J.

Circ Res. 2004 Mar 19;94(5):664-70. Epub 2004 Jan 22.

PMID:
14739162
3.

In vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesis.

Kazenwadel J, Secker GA, Betterman KL, Harvey NL.

PLoS One. 2012;7(7):e40497. doi: 10.1371/journal.pone.0040497. Epub 2012 Jul 6.

4.

Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.

Watari K, Nakao S, Fotovati A, Basaki Y, Hosoi F, Bereczky B, Higuchi R, Miyamoto T, Kuwano M, Ono M.

Biochem Biophys Res Commun. 2008 Dec 19;377(3):826-31. doi: 10.1016/j.bbrc.2008.10.077. Epub 2008 Oct 23.

PMID:
18951870
5.

Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

Kubo H, Cao R, Brakenhielm E, Mäkinen T, Cao Y, Alitalo K.

Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8868-73. Epub 2002 Jun 17.

6.

Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.

Ma X, Ottino P, Bazan HE, Bazan NG.

Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2915-21.

PMID:
15326102
7.

b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern.

Hajrasouliha AR, Sadrai Z, Chauhan SK, Dana R.

Cornea. 2012 Jul;31(7):804-9. doi: 10.1097/ICO.0b013e31823f8b5a.

8.

Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF.

Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y.

Proc Natl Acad Sci U S A. 2001 May 22;98(11):6390-5. Epub 2001 May 8.

9.

The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.

Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Ylä-Herttuala S, Wedge SR, Jürgensmeier JM, Alitalo K.

Cancer Res. 2008 Jun 15;68(12):4754-62. doi: 10.1158/0008-5472.CAN-07-5809.

10.

Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.

Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y, Manabe T.

Pancreas. 2007 May;34(4):444-51.

PMID:
17446844
11.

Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis.

Asai J, Takenaka H, Hirakawa S, Sakabe J, Hagura A, Kishimoto S, Maruyama K, Kajiya K, Kinoshita S, Tokura Y, Katoh N.

Am J Pathol. 2012 Dec;181(6):2217-24. doi: 10.1016/j.ajpath.2012.08.023. Epub 2012 Nov 5.

PMID:
23138019
12.

Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains.

Nakao S, Maruyama K, Zandi S, Melhorn MI, Taher M, Noda K, Nusayr E, Doetschman T, Hafezi-Moghadam A.

FASEB J. 2010 Feb;24(2):504-13. doi: 10.1096/fj.09-134056. Epub 2009 Oct 26.

13.

Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.

Lohela M, Heloterä H, Haiko P, Dumont DJ, Alitalo K.

Am J Pathol. 2008 Dec;173(6):1891-901. doi: 10.2353/ajpath.2008.080378. Epub 2008 Nov 6.

14.

Glucocorticoids suppress corneal lymphangiogenesis.

Steele MM, Kelley PM, Schieler AM, Tempero RM.

Cornea. 2011 Dec;30(12):1442-7. doi: 10.1097/ICO.0b013e318213f39f.

PMID:
21955630
15.

The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.

Al-Rawi MA, Watkins G, Mansel RE, Jiang WG.

Int J Oncol. 2005 Sep;27(3):721-30.

PMID:
16077922
16.

Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action.

Cao R, Björndahl MA, Gallego MI, Chen S, Religa P, Hansen AJ, Cao Y.

Blood. 2006 May 1;107(9):3531-6. Epub 2006 Jan 19.

PMID:
16424394
17.

Angiopoietin-2 promotes inflammatory lymphangiogenesis and its effect can be blocked by the specific inhibitor L1-10.

Yan ZX, Jiang ZH, Liu NF.

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H215-23. doi: 10.1152/ajpheart.00895.2011. Epub 2011 Nov 4.

18.

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.

Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholová I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Ylä-Herttuala S.

Circ Res. 2003 May 30;92(10):1098-106. Epub 2003 Apr 24.

PMID:
12714562
19.

Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.

Mimura T, Amano S, Usui T, Kaji Y, Oshika T, Ishii Y.

Exp Eye Res. 2001 Jan;72(1):71-8.

PMID:
11133184
20.

Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.

Hos D, Regenfuss B, Bock F, Onderka J, Cursiefen C.

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5778-85. doi: 10.1167/iovs.10-6816.

PMID:
21666240

Supplemental Content

Support Center